Clinical Trial Update: Investigating the Effects of Hydroxyvitamin D3 on Multiple Sclerosis [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update investigates the effects of hydroxyvitamin D3 on multiple sclerosis and related conditions.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Multiple Sclerosis Relapsing-remitting
• Vitamin D3 Deficiency

Drugs mentioned

• Hydroxyvitamin D3 (hydroxyvitamin D3)

Snippet

Sponsor: Tehran University of Medical Sciences | Conditions: Multiple Sclerosis, Relapsing-Remitting, Adult ALL | Phase 4 | Status: UNKNOWN